Table 3.
Pre-TIMI flow grade 3 | n (%) |
---|---|
0 | 38 (6.20) |
1 | 14 (2.40) |
2 | 30 (4.90) |
3 | 529 (86.50) |
Média (DP) | |
Reference diameter (mm) | 2.87 (0.46) |
Minimal luminal diameter before the procedure (mm) | 0.92 (0.51) |
Lesion length (mm) | 15.75 (8.37) |
Maximum pressure of the DES implant (ATM) | 14.88 (2.75) |
Final minimal luminal diameter in the stent (mm) | 2.82 (0.48) |
Final minimal luminal diameter in the segment (mm) | 2.41 (0.61) |
Average number of stents / patient | 1.3 |
Type of drug-eluting stent | n (%) |
Costar® | 25 (3.34) |
Cypher® | 255 (34.2) |
Endeavor® | 118 (15.7) |
Infinium® | 9 (1.20) |
Janus® | 6 (0.80) |
Supralimus® | 44 (5.80) |
Taxus® | 291 (38.09) |
Angiographic success | 600 (98.20) |
Post-TIMI flow grade 3 | n (%) |
0 | 1 (0.16) |
1 | 2 (0.32) |
2 | 5(0.81) |
3 | 603 (98.7) |
Use of IIb/IIIa inhibitor | 24 (3.90%) |
Pre-dilation of the lesion | 397 (65.0%) |
The data represent the absolute numbers and percentages or the means and standard deviations.